Display options
Cite
Lindner R. Invariant Chain Complexes and Clusters as Platforms for MIF Signaling. Cells. 2017;6(1)doi: 10.3390/cells6010006.
Lindner, R. (2017). Invariant Chain Complexes and Clusters as Platforms for MIF Signaling. Cells, 6(1), . https://doi.org/10.3390/cells6010006
Lindner, Robert. "Invariant Chain Complexes and Clusters as Platforms for MIF Signaling." Cells vol. 6,1 (2017). doi: https://doi.org/10.3390/cells6010006
Lindner R. Invariant Chain Complexes and Clusters as Platforms for MIF Signaling. Cells. 2017 Feb 10;6(1). doi: 10.3390/cells6010006. PMID: 28208600; PMCID: PMC5371871.
Copy Download .nbib Format: NLM
Share it on

Cells. 2017 Feb 10;6(1). doi: 10.3390/cells6010006.

Invariant Chain Complexes and Clusters as Platforms for MIF Signaling.

Cells

Robert Lindner

Affiliations

  1. Institute of Neuroanatomy and Cell Biology, Hannover Medical School, 30625 Hannover, Germany. [email protected].

PMID: 28208600 PMCID: PMC5371871 DOI: 10.3390/cells6010006

Abstract

Invariant chain (Ii/CD74) has been identified as a surface receptor for migration inhibitory factor (MIF). Most cells that express Ii also synthesize major histocompatibility complex class II (MHC II) molecules, which depend on Ii as a chaperone and a targeting factor. The assembly of nonameric complexes consisting of one Ii trimer and three MHC II molecules (each of which is a heterodimer) has been regarded as a prerequisite for efficient delivery to the cell surface. Due to rapid endocytosis, however, only low levels of Ii-MHC II complexes are displayed on the cell surface of professional antigen presenting cells and very little free Ii trimers. The association of Ii and MHC II has been reported to block the interaction with MIF, thus questioning the role of surface Ii as a receptor for MIF on MHC II-expressing cells. Recent work offers a potential solution to this conundrum: Many Ii-complexes at the cell surface appear to be under-saturated with MHC II, leaving unoccupied Ii subunits as potential binding sites for MIF. Some of this work also sheds light on novel aspects of signal transduction by Ii-bound MIF in B-lymphocytes: membrane raft association of Ii-MHC II complexes enables MIF to target Ii-MHC II to antigen-clustered B-cell-receptors (BCR) and to foster BCR-driven signaling and intracellular trafficking.

Keywords: B-cell receptor; BCR; CD44; CD74; Ii; MHC II; MIF; antigen presentation; invariant chain; membrane raft; migration inhibitory factor

References

  1. EMBO J. 1986 Dec 20;5(13):3483-8 - PubMed
  2. Nature. 2002 Aug 29;418(6901):983-8 - PubMed
  3. Proc Natl Acad Sci U S A. 2005 May 31;102(22):7910-5 - PubMed
  4. Nature. 1991 Dec 5;354(6352):392-4 - PubMed
  5. PLoS One. 2011 Feb 22;6(2):e17257 - PubMed
  6. PLoS One. 2011 Jan 25;6(1):e16428 - PubMed
  7. Mol Immunol. 2015 Dec;68(2 Pt A):102-5 - PubMed
  8. Proc Natl Acad Sci U S A. 1992 Mar 15;89(6):2282-6 - PubMed
  9. Structure. 1997 Nov 15;5(11):1453-64 - PubMed
  10. Blood. 2006 Jun 15;107(12):4807-16 - PubMed
  11. EMBO J. 1996 Jan 15;15(2):418-28 - PubMed
  12. J Cell Commun Signal. 2016 Jun;10(2):165-70 - PubMed
  13. Blood. 2007 Dec 15;110(13):4303-11 - PubMed
  14. J Biol Chem. 1990 Apr 5;265(10):5787-92 - PubMed
  15. J Endocrinol. 2008 Nov;199(2):165-76 - PubMed
  16. J Immunol. 2014 Jun 1;192(11):5273-84 - PubMed
  17. Oncogene. 2007 Aug 2;26(35):5046-59 - PubMed
  18. Proc Natl Acad Sci U S A. 2007 Aug 14;104(33):13408-13 - PubMed
  19. Nature. 2000 Nov 9;408(6809):211-6 - PubMed
  20. J Immunol. 1996 Oct 15;157(8):3404-11 - PubMed
  21. Cell. 2006 Jan 13;124(1):35-46 - PubMed
  22. Expert Opin Ther Targets. 2012 Apr;16 Suppl 2:S17-27 - PubMed
  23. Immunity. 2002 Nov;17(5):549-60 - PubMed
  24. Infect Immun. 2005 Jun;73(6):3783-6 - PubMed
  25. Biochim Biophys Acta. 2016 Jun;1863(6 Pt A):1269-81 - PubMed
  26. FEBS Lett. 2009 Sep 3;583(17):2749-57 - PubMed
  27. Immunity. 2007 Jul;27(1):160-71 - PubMed
  28. EMBO J. 1995 Jan 3;14(1):37-49 - PubMed
  29. Traffic. 2002 Feb;3(2):133-46 - PubMed
  30. Cell. 1993 Jul 30;74(2):257-68 - PubMed
  31. Eur J Cell Biol. 2012 Jun-Jul;91(6-7):435-49 - PubMed
  32. J Immunol. 1999 Nov 15;163(10):5435-43 - PubMed
  33. J Biol Chem. 2016 Jul 22;291(30):15881-95 - PubMed
  34. Cell. 1990 Nov 16;63(4):707-16 - PubMed
  35. J Exp Med. 2013 Jan 14;210(1):31-40 - PubMed
  36. Proc Natl Acad Sci U S A. 2002 Feb 5;99(3):1515-20 - PubMed
  37. Eur J Immunol. 2001 Mar;31(3):841-50 - PubMed
  38. Nat Cell Biol. 2016 Mar;18(3):303-10 - PubMed
  39. Mol Biol Cell. 2005 Nov;16(11):5061-9 - PubMed
  40. Mol Immunol. 1979 Jan;16(1):51-60 - PubMed
  41. J Biol Chem. 2005 Jun 17;280(24):23066-72 - PubMed
  42. Immunity. 1999 Nov;11(5):515-6 - PubMed
  43. EMBO J. 2002 Apr 2;21(7):1650-60 - PubMed
  44. Biochem Biophys Res Commun. 2014 Aug 15;451(1):48-53 - PubMed
  45. J Biol Chem. 1986 Mar 5;261(7):3434-40 - PubMed
  46. J Biol Chem. 2008 May 23;283(21):14453-60 - PubMed
  47. BMC Cancer. 2004 Jul 12;4:34 - PubMed
  48. Hum Immunol. 2015 Apr;76(4):292-6 - PubMed
  49. FASEB J. 2015 Nov;29(11):4497-511 - PubMed
  50. J Immunol. 2015 Aug 15;195(4):1548-63 - PubMed
  51. Trends Biochem Sci. 2011 Jun;36(6):320-8 - PubMed
  52. Curr Opin Immunol. 2014 Feb;26:115-22 - PubMed
  53. J Exp Med. 2013 Jan 14;210(1):23-30 - PubMed
  54. Cell. 1990 Apr 6;61(1):171-83 - PubMed
  55. Annu Rev Immunol. 2010;28:185-210 - PubMed
  56. J Biol Chem. 1996 Sep 27;271(39):24249-56 - PubMed
  57. Eur J Immunol. 2004 Aug;34(8):2230-6 - PubMed
  58. Immunity. 2009 Jan 16;30(1):44-55 - PubMed
  59. EMBO J. 1998 Dec 1;17(23):6812-8 - PubMed
  60. Metab Brain Dis. 2016 Apr;31(2):249-55 - PubMed
  61. Science. 1996 Oct 4;274(5284):106-8 - PubMed
  62. J Biol Chem. 2001 Jul 20;276(29):27203-6 - PubMed
  63. Proc Natl Acad Sci U S A. 1991 Jul 15;88(14):5998-6002 - PubMed
  64. Proc Natl Acad Sci U S A. 2002 Mar 5;99(5):3018-23 - PubMed
  65. Virology. 2009 Mar 30;386(1):23-31 - PubMed
  66. Science. 2006 Jun 16;312(5780):1672-6 - PubMed
  67. J Biol Chem. 2004 Aug 13;279(33):34818-26 - PubMed
  68. Nat Med. 2007 May;13(5):587-96 - PubMed
  69. Cell. 1986 Sep 26;46(7):1103-12 - PubMed
  70. J Exp Med. 1985 Dec 1;162(6):1916-34 - PubMed
  71. J Lipid Res. 2006 Jul;47(7):1597-8 - PubMed
  72. J Exp Med. 2013 Jan 14;210(1):41-58 - PubMed
  73. Nat Immunol. 2005 Nov;6(11):1168-76 - PubMed
  74. Biochemistry. 2006 Apr 25;45(16):5228-34 - PubMed
  75. Nature. 2001 May 24;411(6836):489-94 - PubMed
  76. J Immunol. 1985 Jul;135(1):416-22 - PubMed
  77. J Biol Chem. 1998 Mar 13;273(11):6005-8 - PubMed
  78. J Leukoc Biol. 2014 Nov;96(5):843-55 - PubMed
  79. Leuk Lymphoma. 2011 Aug;52(8):1446-54 - PubMed
  80. Nat Immunol. 2012 Feb 05;13(3):237-45 - PubMed
  81. Immunol Rev. 2008 Feb;221:64-76 - PubMed
  82. J Leukoc Biol. 2005 Nov;78(5):1097-105 - PubMed
  83. J Cell Biol. 1990 Sep;111(3):839-55 - PubMed
  84. J Biol Chem. 2001 Apr 20;276(16):13469-75 - PubMed
  85. Proc Natl Acad Sci U S A. 1996 May 28;93(11):5191-6 - PubMed
  86. J Exp Med. 1996 Apr 1;183(4):1331-8 - PubMed
  87. Immunity. 1999 Jun;10(6):761-8 - PubMed
  88. J Immunol. 1998 May 15;160(10):4850-8 - PubMed
  89. Immunol Cell Biol. 2014 Jul;92(6):553-6 - PubMed
  90. FEBS Lett. 2003 Sep 11;551(1-3):78-86 - PubMed
  91. Blood. 2005 Nov 1;106(9):3160-5 - PubMed
  92. Immunity. 2006 Oct;25(4):595-606 - PubMed
  93. J Biol Chem. 1996 Feb 2;271(5):2863-7 - PubMed
  94. Eur J Cell Biol. 2006 Jun;85(6):457-67 - PubMed
  95. Cell Signal. 2006 May;18(5):688-703 - PubMed
  96. J Immunol. 2014 May 1;192(9):4164-73 - PubMed
  97. J Immunol. 1982 Dec;129(6):2564-9 - PubMed
  98. Proc Natl Acad Sci U S A. 1989 Oct;86(19):7522-6 - PubMed
  99. J Immunol. 2004 Oct 1;173(7):4539-46 - PubMed
  100. Nature. 1990 Jun 14;345(6276):615-8 - PubMed
  101. FEBS Lett. 2012 May 7;586(9):1318-24 - PubMed
  102. Eur J Immunol. 2013 May;43(5):1309-21 - PubMed
  103. Proc Natl Acad Sci U S A. 1993 Sep 15;90(18):8581-5 - PubMed
  104. J Exp Med. 2003 Jun 2;197(11):1467-76 - PubMed
  105. Immunol Cell Biol. 2014 Jul;92(6):471-2 - PubMed
  106. J Cell Sci. 2010 Nov 1;123(Pt 21):3817-27 - PubMed
  107. Am J Pathol. 2012 Dec;181(6):2172-87 - PubMed
  108. Immunity. 1997 Jun;6(6):727-38 - PubMed
  109. Immunol Rev. 1999 Dec;172:109-20 - PubMed
  110. Exp Cell Res. 2009 Oct 15;315(17):2871-8 - PubMed
  111. Nature. 1995 Nov 30;378(6556):457-62 - PubMed
  112. J Mol Biol. 2003 Feb 28;326(4):1157-74 - PubMed
  113. Immunol Cell Biol. 2011 Jul;89(5):619-29 - PubMed
  114. Annu Rev Biochem. 2003;72:395-447 - PubMed
  115. Blood. 2006 Mar 15;107(6):2252-61 - PubMed
  116. Proc Natl Acad Sci U S A. 2011 Aug 23;108(34):E577-85 - PubMed
  117. Nature. 1991 Feb 21;349(6311):669-76 - PubMed
  118. Int Immunol. 2003 Oct;15(10):1249-63 - PubMed
  119. Traffic. 2015 Aug;16(8):871-92 - PubMed
  120. J Cell Sci. 1993 Nov;106 ( Pt 3):831-46 - PubMed
  121. Nat Rev Immunol. 2003 Oct;3(10):791-800 - PubMed
  122. Cancer Biol Ther. 2012 Nov;13(13):1276-83 - PubMed
  123. J Biol Chem. 2008 Feb 1;283(5):2784-92 - PubMed
  124. J Biol Chem. 1999 Jun 18;274(25):18100-6 - PubMed
  125. J Biol Chem. 2005 May 20;280(20):19656-64 - PubMed
  126. Immunity. 2001 Dec;15(6):897-908 - PubMed
  127. J Exp Med. 1993 Mar 1;177(3):583-96 - PubMed
  128. J Mol Biol. 2002 Jul 26;320(5):1109-17 - PubMed
  129. Proc Natl Acad Sci U S A. 2017 Jan 17;114(3):562-567 - PubMed
  130. J Cell Biol. 1994 Jul;126(2):317-30 - PubMed
  131. Proc Natl Acad Sci U S A. 1995 Oct 10;92(21):9900-4 - PubMed

Publication Types